VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
RopivacaIne chlorhydrate
Preclinical
Small molecule
C
Centre Hospitalier Universitaire de Saint Etienne
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Liver Resection
Terminated
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Liver Resection
Preclinical
Terminated
Clinical
Trials by Indication
[1]
Liver Resection
1 trial
Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.
Terminated
·
—
·
N/A
·
NCT02527577
·
39 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for RopivacaIne chlorhydrate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
RopivacaIne chlorhydrate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for RopivacaIne chlorhydrate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Centre Hospitalier Universitaire de Saint Etienne company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
C
Centre Hospitalier Universitaire de Saint Etienne
Related News